MICHELLE HENDRICKX: Open Payments
NPI 1346213014 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,546 in 158 payments from 18 companies in 2025. Trend: 2023 $312 · 2024 $2,001 · 2025 $3,546
Food & beverage: $3,467Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $793 |
| Janssen Biotech, Inc. | 20 | $638 |
| Phathom Pharmaceuticals, Inc. | 17 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $360 |
| PFIZER INC. | 21 | $198 |
| QOL Medical, LLC | 7 | $196 |
| Madrigal Pharmaceuticals | 9 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $171 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Lilly USA, LLC | 4 | $93 |
Products named: TREMFYA, VOQUEZNA, LINZESS, ENTYVIO, Sucraid, REZDIFFRA, DUPIXENT, RINVOQ.
Industry payments across WA — which companies pay providers there.
